Biosite announced this week a collaboration with Hopitaux Universitaires de Geneve to identify biomarkers linked to acute kidney injury and acute renal failure.
The deal follows an earlier biomarker-identification agreement between San Diego-based Biosite and the Cincinnati Children’s Hospital Medical Center and Columbia University in the area of kidney disease.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
Try GenomeWeb Premium now.
Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
